The global benzodiazepine drugs industry continues to witness steady growth due to the increasing prevalence of anxiety disorders, insomnia, seizure conditions, and alcohol withdrawal syndrome worldwide. Benzodiazepines remain among the most prescribed central nervous system medications because of their fast-acting sedative and anxiolytic properties. Rising awareness regarding mental health...

The global peptide and anticoagulant drugs market is witnessing substantial growth due to the rising prevalence of cardiovascular diseases, diabetes, cancer, and chronic disorders worldwide. Pharmaceutical companies are increasingly investing in advanced peptide therapeutics and innovative anticoagulant formulations to improve patient outcomes and reduce side effects. Growing awareness...